Maxacalcitol (22-Oxacalcitriol)) CAS No. 103909-75-7 with High Purity 99.0%Min. Small Molecule Compounds Hyperparathyroidism, Psoriasis

China Maxacalcitol (22-Oxacalcitriol)) CAS No. 103909-75-7 with High Purity 99.0%Min. Small Molecule Compounds Hyperparathyroidism, Psoriasis, Find details about China Falecalcitriol, Fesoterodine from Maxacalcitol (22-Oxacalcitriol)) CAS No. 103909-75-7 with High Purity 99.0%Min. Small Molecule Compounds Hyperparathyroidism, Psoriasis

Model NO.
99.0%MN.
Trademark
Excelente
Transport Package
1vial/Box
Specification
5mg/vial; 10mg/vial
Origin
China
Model NO.
99.0%MN.
Trademark
Excelente
Transport Package
1vial/Box
Specification
5mg/vial; 10mg/vial
Origin
China
CAS No. 103909-75-7 with High Purity 99.0%Min. Small Molecule Compounds  Hyperparathyroidism,Psoriasis

(Synonyms: 22-Oxacalcitriol)

[ Purity ]99.5%

Description

Maxacalcitol (22-Oxacalcitriol) is non-calcemic vitamin D3 analog and ligand of VDR-like receptors. IC50 value: Target: Maxacalcitol (22-Oxacalcitriol)suppresses parathyroid hormone (PTH) mRNA expression in vitro and in vivo. Maxacalcitol exhibits similar effects to calcitriol in osteoblast-like cells. Maxacalcitol(22-Oxacalcitriol) inhibits tumor growth of osteosarcoma in vitro in combination with all-trans retinoic acid.

Clinical Trial
NCT NumberSponsorConditionStart DatePhase
NCT00990704AbbottSecondary Hyperparathyroidism|HemodialysisOctober 2009Phase 2
NCT01341782AbbVie (prior sponsor, Abbott)|AbbVieSecondary Hyperparathyroidism|HemodialysisMay 2011Phase 3
NCT00667576Abbott|Abbott Japan Co.,LtdChronic Kidney Disease on Hemodialysis|Secondary HyperparathyroidismApril 2008Phase 2
Molecular Weight

418.61

Formula

C26H42O4

CAS No.

103909-75-7

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1)

Only for Research & Lab Use,not for human use.

We also supply the following small molecule chemical compounds as follows:
Maxacalcitol (22-Oxacalcitriol)) CAS No. 103909-75-7 with High Purity 99.0%Min. Small Molecule Compounds Hyperparathyroidism, Psoriasis
Maxacalcitol (22-Oxacalcitriol)) CAS No. 103909-75-7 with High Purity 99.0%Min. Small Molecule Compounds Hyperparathyroidism, Psoriasis
Maxacalcitol (22-Oxacalcitriol)) CAS No. 103909-75-7 with High Purity 99.0%Min. Small Molecule Compounds Hyperparathyroidism, Psoriasis
Maxacalcitol (22-Oxacalcitriol)) CAS No. 103909-75-7 with High Purity 99.0%Min. Small Molecule Compounds Hyperparathyroidism, Psoriasis
Maxacalcitol (22-Oxacalcitriol)) CAS No. 103909-75-7 with High Purity 99.0%Min. Small Molecule Compounds Hyperparathyroidism, Psoriasis
Maxacalcitol (22-Oxacalcitriol)) CAS No. 103909-75-7 with High Purity 99.0%Min. Small Molecule Compounds Hyperparathyroidism, Psoriasis
Maxacalcitol (22-Oxacalcitriol)) CAS No. 103909-75-7 with High Purity 99.0%Min. Small Molecule Compounds Hyperparathyroidism, Psoriasis
Maxacalcitol (22-Oxacalcitriol)) CAS No. 103909-75-7 with High Purity 99.0%Min. Small Molecule Compounds Hyperparathyroidism, Psoriasis


Just for Research&Lab use,not for human use . 

Pharmaceuticals Peptide Seractide ACTH (1-39) for Muscle Building with Safe Delivery
Pharmaceuticals Peptide Seractide ACTH (1-39) for Muscle Building with Safe Delivery